Using the extensive dataset in this study, we directly calculated dN/dS for PTEN benchmarked to the oncogenes KRAS and PIK3CA, and the tumor suppressors APC and TP53, considering non-truncating and truncating mutations separately (Fig. 2a). The gene discussed is PTEN; the disease is neoplasm.